To purchase hard copies of this book, please email:
orders@intechopen.com
By only printing on demand InTech ensures our carbon footprint is kept to a minimum.
The data below shows the environmental impact of printing one single book:
54.26 kg wood
2.92 g CO2
49.26 ml Water
Share this page
Understanding Tuberculosis - New Approaches to Fighting Against Drug Resistance
Edited by Pere-Joan Cardona, ISBN 978-953-307-948-6, Hard cover, 376 pages, Publisher: InTech, Published: February 15, 2012 under CC BY 3.0 license, in subject Infectious Diseases
DOI: 10.5772/2477
In 1957, a Streptomyces strain, the ME/83 (S.mediterranei), was isolated in the Lepetit Research Laboratories from a soil sample collected at a pine arboretum near Saint Raphael, France. This drug was the base for the chemotherapy with Streptomicine. The euphoria generated by the success of this regimen lead to the idea that TB eradication would be possible by the year 2000. Thus, any further drug development against TB was stopped. Unfortunately, the lack of an accurate administration of these drugs originated the irruption of the drug resistance in Mycobacterium tuberculosis. Once the global emergency was declared in 1993, seeking out new drugs became urgent. In this book, diverse authors focus on the development and the activity of the new drug families.
This book is indexed in:
Book contents
- Chapter 1Multi-Drug/Extensively Drug Resistant Tuberculosis (Mdr/Xdr-Tb): Renewed Global Battle Against Tuberculosis?
- Chapter 2Chemotherapeutic Strategies and Targets Against Resistant TB
- Chapter 3A New Hope in TB Treatment: The Development of the Newest Drugs
- Chapter 4In Search of El Dorado: Current Trends and Strategies in the Development of Novel Anti-Tubercular Drugs
- Chapter 5An Approach to the Search for New Drugs Against Tuberculosis
- Chapter 6Antitubercular In Vitro Drug Discovery: Tools for Begin the Search
- Chapter 7New Antitubercular Drugs Designed by Molecular Modification
- Chapter 8The Cord Factor: Structure, Biosynthesis and Application in Drug Research – Achilles Heel of Mycobacterium tuberculosis?
- Chapter 9Old and New TB Drugs: Mechanisms of Action and Resistance
- Chapter 10Pyrazinecarboxylic Acid Derivatives with Antimycobacterial Activity
- Chapter 11The Potential Therapeutic Usage of Dithiocarbamate Sugar Derivatives for Multi-Drug Resistant Tuberculosis
- Chapter 12Fighting Against Resistant Strains: The Case of Benzothiazinones and Dinitrobenzamides
- Chapter 13Quinolone Resistance in Tuberculosis Treatment: A Structural Overview
- Chapter 14Antimycobacterial Activity Some Different Lamiaceae Plant Extracts Containing Flavonoids and Other Phenolic Compounds
- Chapter 15Cinnamic Derivatives in Tuberculosis
- Chapter 16Potential Use of I. suffruticosa in Treatment of Tuberculosis with Immune System Activation
